Medications

Pharma giant Novartis working on H7N9 vaccine

Swiss pharmaceuticals giant Novartis is researching a vaccine for the H7N9 strain of bird flu, its chief executive said Thursday, amid fears that the disease could mutate into a form that spreads among people.

Diseases, Conditions, Syndromes

Singapore announces first local coronavirus transmissions

Singapore on Tuesday announced the first local transmissions of the deadly coronavirus from China as a major aviation conference was scrapped due to the escalating health scare.

Diseases, Conditions, Syndromes

US health authorities in bird flu vaccine effort

US health authorities are liaising with domestic and international partners to develop a vaccine for the H7N9 bird flu virus that has killed five people in China.

Diseases, Conditions, Syndromes

WHO insists it hid nothing, sounded virus alarm from start

The World Health Organization insisted Monday that it sounded the alarm on the novel coronavirus right from the very start and had hidden nothing from Washington about the deadly pandemic.

Diseases, Conditions, Syndromes

H7N9 vaccine may take months, CDC says (Update)

US public health experts said developing a vaccine for the H7N9 strain of bird flu could take "many months", as China seeks to control an outbreak which had killed 11 people by Friday.

Diseases, Conditions, Syndromes

China bird flu spreads to new province

China on Tuesday said the H7N9 bird flu had spread to a new area as it confirmed the first case in the eastern province of Shandong in an outbreak which has so far killed 22 people.

Medications

Octaplas approved for blood-clotting disorders

(HealthDay)—Octaplas has been approved by the U.S. Food and Drug Administration to augment insufficient clotting proteins that could otherwise lead to excessive bleeding or excessive clotting.

page 15 from 18